Investors / China / Viva BioInnovator
Viva BioInnovator
Corporate VC · Shanghai, China · Asia Pacific
Viva BioInnovator is the investment division of Viva Biotech Holdings, investing globally in early-stage biotech companies. It provides cash and Equity-for-Services investments and offers a hands-on incubation track for a select group of founders.
Invests inHealthcare & Biotech
In its own wordsbiotechtherapeuticsdrug discoverydevicesdiagnosticslife science tools
Your fit with Viva BioInnovator
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsViva BioInnovator lists 38 checked portfolio companies on its own site and is named in 1 funding round. Its most frequent entry is Series B, 100% of the companies with a known first round. Its largest themes are Healthcare & Biotech (95%), AI & Machine Learning (3%) and Media & Entertainment (3%). 61% of its companies are based in United States. It invests most often alongside Broadview Ventures, Portal Innovations and CTI Life Sciences Fund.
Counts come from funding rounds that name Viva BioInnovator, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Viva BioInnovator's whole history. Rounds on record name 1 company; its own site lists 38. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 0% |
| Series B | 100% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 0 | 0 |
| '26 | 1 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 76th | 38 companies |
| Recent activity | 59th | 1 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 56th | 3% of companies confirmed by a round |
| Sector focus | 97th | 95% in its largest sector |
| Reach | 91th | 8 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Broadview Ventures | 3 |
| Portal Innovations | 3 |
| CTI Life Sciences Fund | 2 |
| Creative Destruction Lab | 2 |
| Insight Partners | 2 |
| Lumira Ventures | 2 |
| Mission BioCapital | 2 |
| Myeloma Investment Fund | 2 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers3797%
- No longer answers00%
- Points to another company13%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 95% | 15% |
| AI & Machine Learning | 3% | 18% |
| Media & Entertainment | 3% | 4% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Broadview Ventures
Compare Viva BioInnovator head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Viva BioInnovator| Date | Company | Stage |
|---|---|---|
| 10 Feb 2026 | Series B |
Round details for Viva BioInnovator
Amounts, full round histories and every co-investor in Viva BioInnovator's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
38 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Acelink Therapeutics is a clinical-stage drug development company that develops groundbreaking therapies for diseases of glycolipid metabolism. | Healthcare & Biotech | Portfolio page | ||
| Acurastem is a patient-based biotechnology company pioneering how treatments are developed for neurodegenerative diseases | Healthcare & Biotech | Portfolio page | ||
| Aleta Biotherapeutics develops biologic therapies to enhance the effectiveness of CAR T cell therapies in treating cancer. | Healthcare & Biotech | Portfolio page | ||
| AmacaThera develops a hydrogel drug delivery platform for precise and sustained release of therapeutics | Healthcare & Biotech | Portfolio page | ||
| Amberstone Biosciences develops immunotherapies | Healthcare & Biotech | Portfolio page | ||
| Antag Therapeutics is pioneering a new class of therapies for people living with obesity, diabetes and overweight. | Healthcare & Biotech | Portfolio page | ||
| ArrePath discovers oral small-molecule drugs using artificial intelligence and machine learning | Healthcare & Biotech | Portfolio page | ||
| Arthrosi Therapeutics is a clinical-stage biotech company focused on the development of therapy for gout and chronic kidney disease. | Healthcare & Biotech | Portfolio page | ||
| Basking Biosciences is developing a targeted, highly specific, short-acting therapy with a direct-acting reversal agent to treat life-threatening clots | Healthcare & Biotech | Portfolio page | ||
| Bright Angel Therapeutics is a pre-clinical stage biotechnology company focused on the development of novel therapeutics for the treatment of drug-resistant and life-threatening fungal infections. | Healthcare & Biotech | Portfolio page | ||
| Cybrexa Therapeutics is developing a new class of therapeutics that directly targets the tumor microenvironment to help improve patients' lives | Healthcare & Biotech | Portfolio page | ||
| Dogma Therapeutics discovers and develops small molecule inhibitors of PCSK9 function | Healthcare & Biotech | Portfolio page | ||
| Domain Therapeutics develops breakthrough GPCR-targeting therapies for patients, especially in immuno-oncology and inflammation. | Healthcare & Biotech | Feb 2026Series B | Page + round | |
| Portfolio page | ||||
| Elgia creates innovative medicines for debilitating chronic diseases | Healthcare & Biotech | Portfolio page | ||
| Grove Biopharma is pioneering Bionic Biologics, a breakthrough synthetic modality for developing novel therapeutics that target intracellular protein-protein interactions. | Healthcare & Biotech | Portfolio page | ||
| Haya Therapeutics develops RNA-guided therapies to reverse disease-driving cell states and restore health. | Healthcare & Biotech | Portfolio page | ||
| The company develops biologics and peptides for various diseases, including obesity and cardio-renal-metabolic diseases. | Healthcare & Biotech | Portfolio page | ||
| Iterion Therapeutics is a clinical-stage, biopharmaceutical company developing novel therapeutics for cancer. | Healthcare & Biotech | Portfolio page | ||
| Mebias Discovery identifies molecules that bind to G-protein coupled receptor targets to develop novel drugs | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- vivabioinnovator.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 10 Feb 2026
- Companies checked
- 38
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Viva BioInnovator's profile as data
Pull Viva BioInnovator's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/vivabioinnovator.com
# also
GET /v1/firms/vivabioinnovator.com/portfolio
GET /v1/firms/vivabioinnovator.com/coinvestors
GET /v1/firms/vivabioinnovator.com/news